companydata.dkcompanydata.dk

Merck Life Science A/S: Financial statements 2020

CVR: 20830131

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 768,192,545 and a net result of DKK 41,276,750 compared with DKK 27,387,479 the year before. The profit margin was 5.4%. Equity in the 2020 report amounted to DKK 176,967,611. The solvency ratio was 74.6%. The company had 16 employees in the financial year.

Revenue
DKK 768,192,545
Gross Profit
DKK 72,096,115
Profit/Loss
DKK 41,276,750
Equity
DKK 176,967,611
Total Assets
DKK 237,290,428
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020768.2M72.1M41.3M177M16
2019-53.4M27.4M135.7M9
2018-26.9M16.7M67.1M14
2017-21.3M8.6M50.4M16
2016-20.3M6.2M41.7M17

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Merck Life Science A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Merck Life Science A/S: The 2019 annual report is outSep 24, 2020

Merck Life Science A/S has published its annual report for 2019. Gross profit came to DKK 53,447,114, and the net result was DKK 27,387,479.

David Mouyal joins the board of Merck Life Science A/SApr 29, 2020

As of April 29, 2020, David Mouyal has joined the board of directors of Merck Life Science A/S.

Jeanette Sandholmen leaves the board of Merck Life Science A/SApr 29, 2020

As of April 29, 2020, Jeanette Sandholmen has left the board of directors of Merck Life Science A/S.

About Merck Life Science A/S

Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.

Source: annual report 2025, Danish Business Authority